These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4846882)

  • 1. [Value of urine hydroxyproline determination in patients with lung neoplasms].
    Pawelec D
    Pol Tyg Lek; 1974 Jul; 29(27):1159-60. PubMed ID: 4846882
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the unification of the expression of results of determination of steroid hormones in urine].
    Bershteĭn LM
    Lab Delo; 1969; 6():375-7. PubMed ID: 4185848
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of hormone studies for the control of the treatment effectiveness of squamous-cell cancer of the lung].
    Chirvina ED; Tiutiunova AM; Kartashov SZ
    Vopr Onkol; 1980; 26(11):91-5. PubMed ID: 7456432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary excretion of 5-hydroxyproline in lung cancer].
    Brocard H; Akoun G; Bruhat M; Bayard D
    Sem Hop; 1968 Jul; 44(32):2157-9. PubMed ID: 4300356
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermal growth factor receptor ectodomain in the urine of patients with squamous cell carcinoma.
    Witters LM; Curley EM; Kumar R; Chinchilli VM; Harvey JP; Crebbin V; Harvey HA; Lipton A
    Clin Cancer Res; 1995 May; 1(5):551-7. PubMed ID: 9816015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary polyamines measured by HPLC in lung cancer].
    Zen XL
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):22-4, 62-3. PubMed ID: 3197166
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-aminoisobutyric acid in urine from patients with urothelial tumours.
    Nielsen HR; Nyholm K; Sjölin KE
    Rev Eur Etud Clin Biol; 1971 May; 16(5):444-50. PubMed ID: 5113307
    [No Abstract]   [Full Text] [Related]  

  • 8. Urine calcitonin levels in patients with bronchogenic carcinoma.
    Becker KL; Nash DR; Silva OL; Snider RH; Moore CF
    JAMA; 1980 Feb; 243(7):670-2. PubMed ID: 6243372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
    Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
    Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of the determination of urinary hydroxyproline (OH-P) in a group of patients with various neoplasms].
    De Benedetto A; Marchei GG; Cardinale G; Michetti M; Marchei P; Reale MG
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):275. PubMed ID: 2092132
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hydroxyproline and lung diseases].
    Pawelec D
    Pol Tyg Lek; 1975 Jun; 30(25):1081-2. PubMed ID: 1135089
    [No Abstract]   [Full Text] [Related]  

  • 12. The urinary excretion of cAMP in patients with malignant tumours.
    Van der Velden PC; Naafs MA; Fischer HR; Hackeng WH; Koorevaar G; Schopman W; Silberbusch J
    Neth J Med; 1983; 26(1):10-7. PubMed ID: 6300710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urinary hydroxyproline in some non-specific lung diseases].
    Pawelec D
    Pol Tyg Lek; 1972 Jul; 27(30):1161-3. PubMed ID: 5073023
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of specific urinary hydroxyproline-containing peptides in patients with lung cancer.
    Svojtková E; Macek K; Deyl Z; Adam M
    J Chromatogr; 1980 Aug; 183(2):221-5. PubMed ID: 7400280
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of hydroxyproline determination in the 24-hour urine].
    Oberländer V; Bottermann P
    Verh Dtsch Ges Inn Med; 1974; 80():1402-4. PubMed ID: 4454438
    [No Abstract]   [Full Text] [Related]  

  • 17. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of hydroxyproline determination in the urine in rheumatoid arthritis].
    Eisner M; Wysocka K; Kondraciuk A; Czalczyńska A
    Reumatologia; 1969; 7(3):225-31. PubMed ID: 5367154
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.
    Pedersen H; Brünner N; Francis D; Osterlind K; Rønne E; Hansen HH; Danø K; Grøndahl-Hansen J
    Cancer Res; 1994 Sep; 54(17):4671-5. PubMed ID: 8062262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.